Co-Diagnostics to Seek FDA EUA for At-Home PCR Diagnostic System, COVID Test in Q1
Newly merged with a firm founded by BioFire Diagnostics alums, Co-Diagnostics plans to develop small panels for the system with up to six targets.
Stay updated with breaking news from Dwight Egan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Newly merged with a firm founded by BioFire Diagnostics alums, Co-Diagnostics plans to develop small panels for the system with up to six targets.
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
CoSara's new multiplex test is built on the Co-Diagnostics' patented CoPrimer technology and designed to detect and differentiate between HPV...
SALT LAKE CITY, Jan. 13, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,... | January 13, 2022
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...